| Literature DB >> 30171260 |
David Stieglitz1, Susanne Lamm1, Simone Braig2, Lena Feuerer1, Silke Kuphal1, Peter Dietrich1, Stephanie Arndt3, Bernd Echtenacher4, Claus Hellerbrand1,5, Sigrid Karrer3, Anja-Katrin Bosserhoff6,7.
Abstract
Melanoma is the deadliest form of skin cancer with rising incidence, creating a significant health problem. We discovered increased expression of bone morphogenetic protein 6 (BMP6) in melanoma cells and tissues, and observed that BMP6 deficiency caused significantly delayed tumor onset and decelerated tumor progression in a melanoma mouse model. Moreover, we determined that BMP6 inhibits dermal mast cell recruitment and found that mast cell-derived mediators significantly reduced melanoma growth in vitro. In line with this, mast cell deficiency accelerated tumor onset and progression in a melanoma mouse model. Analysis of human melanoma tissues revealed a strong negative correlation between melanoma proliferation and mast cell infiltration. This study elucidates a novel role of BMP6-induced modulation of the tumor microenvironment.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30171260 DOI: 10.1038/s41388-018-0475-x
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 9.867